Trial intelligence / Profile preview

ECLECTIC: L-Carnitine + Cilostazol in PAD

NCT00822172Phase 4Completed

Sponsor
CPC Clinical Research
Start
Sep 2008
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levocarnitine in intermittent claudication (IC), sponsored by CPC Clinical Research. Started Sep 2008; status: completed.

02

Drugs

levocarnitine
03

Conditions

intermittent claudication (IC)

Beyond the preview

Go deeper on NCT00822172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00822172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call